Esophagitis Clinical Trials in Boston, Massachusetts
7 recruitingBoston, Massachusetts
Showing 1–7 of 7 trials
Recruiting
Phase 3
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
eosinophilic esophagitis
Dr. Falk Pharma GmbH308 enrolled27 locationsNCT06596252
Recruiting
Phase 3
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
Eosinophilic Esophagitis (EoE)
Regeneron Pharmaceuticals20 enrolled11 locationsNCT07112378
Recruiting
A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
Eosinophilic Esophagitis (EoE)
Regeneron Pharmaceuticals350 enrolled55 locationsNCT06693531
Recruiting
Phase 2
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
eosinophilic esophagitis
Phathom Pharmaceuticals, Inc.80 enrolled41 locationsNCT06851559
Recruiting
Not Applicable
Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
Inflammatory Bowel DiseasesCrohn DiseaseCrohn's Ileocolitis+5 more
Massachusetts General Hospital80 enrolled1 locationNCT05332639
Recruiting
OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
eosinophilic esophagitisEosinophilic GastritisEosinophilic Gastrointestinal Disorders (EGIDs)+2 more
Children's Hospital Medical Center, Cincinnati1,350 enrolled19 locationsNCT02523118
Recruiting
Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
Ulcerative Colitis (UC)Inflammatory Bowel Disease (IBD)Indeterminate Colitis+10 more
Massachusetts General Hospital50 enrolled1 locationNCT06655415